Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas

British Journal of Cancer

Volumn 88, Issue 6, 2003, Pages 863-870

  Bieche I ^a,b   Girault, I ^a   Sabourin, J C ^a   Tozlu, S ^a   Driouch, K ^a   Vidaud, M ^b   Lidereau, R ^a  

^a CENTRE RENÉ HUGUENIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Breast cancer; Maspin gene expression; Prognostic value; Real time RT PCR quantification

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MASPIN; MESSENGER RNA;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER SURGERY; CELL MIGRATION; CLINICAL FEATURE; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0242668419     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600812     Document Type: Article

References (32)

1. Bièhe I, Nogués C, Lidereau R (1999a) Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene 18: 5232-5238
2. Bièhe I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M (1999b) Real-time reverse transcription - PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45: 1148-1156
3. Bièhe I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R (2001) Quantitation of estrogen receptor α and β expression in sporadic breast cancer. Oncogene 20: 8109-8115
4. Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34: 187-220
5. Domann FE, Rice JC, Hendrix MJ, Futscher BW (2000) Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85: 805-810
6. Hojo T, Akiyama Y, Nagasaki K, Maruyama K, Kikuchl K, Ikeda T, Kitajima M, Yamaguchi K (2001) Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett 171: 103-110
7. Jiang WG, Hiscox S, Horrobin DF, Bryce RP, Mansel RE (1997) γ Linolenic acid regulates expression of maspin and the motility of cancer cells. Biochem Biophys Res Commun 237: 639-644
8. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S (2002) Maspin sensitizes breast carcinoma cells to induced apoptosls. Oncogene 21: 4089-4098
9. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
10. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W, Nagasaki K (2001a) Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 34: 303-307
11. Maass N, Hojo T, Ueding M, Lüttges J, Klöppel G, Jonat W, Nagasaki K (2001c) Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817
12. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P (2001b) Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 195: 321-326
13. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan C-P, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, Pardee AB, Sager R (2000) Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 60: 2232-2238
14. Merrie AE, Yun K, Gunn J, Phillips LV, Mc Call JL (1999) Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer. Br J Cancer 80: 2019-2024
15. Pemberton PA, Tipton AR, Pavloff N, Smith J, Erickson JR, Mouchabeck ZM, Kiefer MC (1997) Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J Histochem Cytochem 45: 1697-1706
16. Peto R, Pike MC, Armitage P (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39
17. Sabbatini R, Frederico M, Morselli M, Depenni R, Cagossi K, Luppi M, Torelli G, Silingardi V (2000) Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol 18: 1914-1920
18. Seftor REB, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJC (1998) Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58: 5681-5685
19. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJC, Sager R (1996) Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674
20. Sheng S, Truong B, Fredrickson D, Wu R, Pardee AB, Sager R (1998) Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci USA 95: 499-504
21. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D, Zhang M (2001) Blocking tumor growth, invasion, and metastasis by maspin in syngeneic breast cancer model. Cancer Res 61: 6945-6951
22. Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL (1999) Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 59: 5421-5424
23. Stal O, Borg A, Fernö M, Kallström A-C, Malmström P, Nordenskjöld B and members of the South Sweden Breast Cancer Group and the Southeast Sweden Breast Cancer Group (2000) ErbB2 status and the benefit from two of five years of adjuvant tamoxifen in postmenopausal early stage breast cancer. Ann Oncol 11: 1545-1550
24. Stephens RW, Brunner N, Janicke F, Schmitt M (1998) The urokinase plasminogen activator system as a target for prognostic studies in breast cancer. Breast Cancer Res Treat 52: 99-111
25. Sternlicht MD, Barsky SH (I997) The myoepithelial defense: a host defense against cancer. Med Hypotheses 48: 37-46
26. Streuli CH (2002) Maspin is a tumour supressor that inhibits breast cancer tumour metastasis in vivo. Breast Cancer Res 4: 137-140
27. Umerika Y, Ohi Y, Sagara Y, Yoshida H (2002) Expression of maspin predicts poor prognosis in breast cancer patients. Int J Cancer 100: 452-455
28. Zhang M, Maass N, Magit D, Sager R (1997) Transactivation through Ets and Ap1 transcriptional sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 8: 179-186
29. Zhang M, Shi Y, Magit D, Furth PA, Sager R (2000b) Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene 19: 6053-6058
30. Zhang M, Volpert O, Shi YH, Bouck N (2000a) Maspin is an angiogenesis inhibitor. Nat Med 6: 196-1999
31. Zou Z, Anisowicz A, Hendrix MJC, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529
32. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S (2000) P53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275: 6051-6054